Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$691.15M
Total Bought:
$264.47M
Total Sold:
$308.28M
Net Transaction:
-$43.81M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADS(ABVX)539,704422,193-117,511$45.82M$56.93M8.24%+$11.11M
Cogent Biosciences, Inc.(COGT)815,0751,245,254+430,179$11.70M$44.23M6.40%+$32.53M
UroGen Pharma Ltd.(URGN)1,577,2831,738,821+161,538$31.47M$40.72M5.89%+$9.26M
Kalvista Pharmaceuticals Inc1,363,3782,427,118+1,063,740$16.61M$39.20M5.67%+$22.59M
Celcuity Inc.(CELC)88,686375,132+286,446$4.38M$37.42M5.41%+$33.03M
Nuvalent Inc372,300311,430-60,870$32.20M$31.33M4.53%-$869.8K
Dianthus Therapeutics, Inc.(DNTH)674,966750,136+75,170$26.56M$30.91M4.47%+$4.35M
Kodiak Sciences Inc.(KOD)1,000,0001,023,122+23,122$16.37M$28.61M4.14%+$12.24M
Praxis Precision Medicines, Inc.(PRAX)51,21082,465+31,255$2.71M$24.31M3.52%+$21.59M
Immunome, Inc.(IMNM)01,126,210+1,126,210$0$24.19M3.50%+$24.19M
Fractyl Health, Inc.(GUTS)10,600,0009,840,041-759,959$16.85M$21.65M3.13%+$4.79M
Monte Rosa Therapeutics, Inc.(GLUE)694,9421,029,066+334,124$5.15M$16.14M2.33%+$10.99M
Veracyte, Inc.(VCYT)235,791357,558+121,767$8.09M$15.05M2.18%+$6.96M
CG Oncology, Inc.(CGON)638,346361,158-277,188$25.71M$15.00M2.17%-$10.72M
Rhythm Pharmaceuticals, Inc.(RYTM)369,996135,950-234,046$37.37M$14.55M2.11%-$22.81M
Syndax Pharmaceuticals, Inc.(SNDX)463,708642,899+179,191$7.13M$13.51M1.95%+$6.37M
Biogen Inc.(BIIB)80,41975,412-5,007$11.27M$13.27M1.92%+$2.01M
Insmed Incorporated(INSM)206,64871,256-135,392$29.76M$12.40M1.79%-$17.36M
Centessa Pharmaceuticals PlcADS141,238458,203+316,965$3.43M$11.46M1.66%+$8.03M
Viridian Therapeutics, Inc.(VRDN)259,509348,569+89,060$5.60M$10.85M1.57%+$5.25M
Ascendis Pharma A/SADR(ASND)53,55449,228-4,326$10.65M$10.50M1.52%-$149.7K
Pfizer Inc.(PFE)0419,134+419,134$0$10.44M1.51%+$10.44M
Benitec Biopharma Inc.(BNTC)276,267731,717+455,450$3.88M$9.86M1.43%+$5.98M
Avalo Therapeutics, Inc.(AVTX)720,922524,436-196,486$9.16M$9.52M1.38%+$360.8K
Guardant Health, Inc.(GH)091,914+91,914$0$9.39M1.36%+$9.39M
ORIC Pharmaceuticals, Inc.(ORIC)1,948,8081,116,604-832,204$23.39M$9.13M1.32%-$14.25M
Vaxcyte, Inc.(PCVX)314,339148,787-165,552$11.32M$6.87M0.99%-$4.46M
Trevi Therapeutics, Inc.(TRVI)588,789541,240-47,549$5.39M$6.78M0.98%+$1.39M
Gossamer Bio, Inc.(GOSS)4,779,0822,135,722-2,643,360$12.57M$6.62M0.96%-$5.95M
Spyre Therapeutics, Inc.(SYRE)0187,737+187,737$0$6.15M0.89%+$6.15M
Lexeo Therapeutics, Inc.(LXEO)778,611617,608-161,003$5.17M$6.13M0.89%+$962.9K
Amylyx Pharmaceuticals, Inc.(AMLX)700,000506,242-193,758$9.51M$6.12M0.88%-$3.40M
Cerus Corporation(CERS)2,715,7862,814,383+98,597$4.32M$5.80M0.84%+$1.48M
Compass Therapeutics, Inc.(CMPX)2,833,9881,051,343-1,782,645$9.92M$5.65M0.82%-$4.27M
Soleno Therapeutics Inc0117,485+117,485$0$5.44M0.79%+$5.44M
Compugen Ltd.(CGEN)3,311,1653,479,805+168,640$4.87M$5.32M0.77%+$456.7K
Celldex Therapeutics, Inc.(CLDX)348,922191,074-157,848$9.03M$5.19M0.75%-$3.84M
Olema Pharmaceuticals, Inc.(OLMA)933,541206,280-727,261$9.14M$5.16M0.75%-$3.98M
Erasca, Inc.(ERAS)1,368,0751,317,584-50,491$2.98M$4.90M0.71%+$1.92M
Fulcrum Therapeutics, Inc.(FULC)0394,650+394,650$0$4.46M0.65%+$4.46M
Aardvark Therapeutics Inc306,912303,939-2,973$4.08M$3.99M0.58%-$89.7K
C4 Therapeutics, Inc.(CCCC)1,897,3831,994,224+96,841$4.21M$3.81M0.55%-$403.2K
Surrozen, Inc.(SRZN)0157,323+157,323$0$3.56M0.51%+$3.56M
Contineum Therapeutics, Inc.CL A(CTNM)166,161307,540+141,379$1.95M$3.52M0.51%+$1.56M
Mineralys Therapeutics, Inc.(MLYS)80,00094,983+14,983$3.03M$3.45M0.50%+$413.3K
Relay Therapeutics, Inc.(RLAY)0398,167+398,167$0$3.37M0.49%+$3.37M
Abeona Therapeutics Inc.(ABEO)994,754627,738-367,016$5.25M$3.31M0.48%-$1.94M
TELA Bio, Inc.(TELA)2,782,9232,647,512-135,411$4.15M$3.12M0.45%-$1.02M
uniQure N.V.SHS(QURE)455,000126,047-328,953$26.56M$3.02M0.44%-$23.54M
Tarsus Pharmaceuticals, Inc.(TARS)036,124+36,124$0$2.96M0.43%+$2.96M
Kymera Therapeutics, Inc.(KYMR)034,589+34,589$0$2.69M0.39%+$2.69M
Nextcure Inc0176,057+176,057$0$2.50M0.36%+$2.50M
Elutia Inc.CL A(ELUT)2,850,9872,751,314-99,673$2.54M$1.91M0.28%-$632.1K
Sionna Therapeutics, Inc.(SION)108,80141,460-67,341$3.20M$1.71M0.25%-$1.49M
CytomX Therapeutics, Inc.(CTMX)0385,974+385,974$0$1.64M0.24%+$1.64M
X4 Pharmaceuticals, Inc.(XFOR)0357,387+357,387$0$1.43M0.21%+$1.43M
Edgewise Therapeutics, Inc.(EWTX)042,052+42,052$0$1.04M0.15%+$1.04M
Radiopharm Theranostics LimitedADS(RADX)187,406187,4060$1.03M$978.3K0.14%-$56.2K
4d Molecular Therapeutics In0100,000+100,000$0$750.0K0.11%+$750.0K
Adagio Medical Holdings, Inc.(ADGM)0515,384+515,384$0$536.0K0.08%+$536.0K
Rapport Therapeutics, Inc.(RAPP)203,9469,659-194,287$6.06M$293.1K0.04%-$5.76M
Palisade Bio, Inc.(PALI)0102,108+102,108$0$240.0K0.03%+$240.0K
iBio, Inc.(IBIO)0106,000+106,000$0$204.6K0.03%+$204.6K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,828104,8280$4.1K$2.5K0.00%-$1.6K
Akero Therapeutics Inc643,6360-643,636$30.56M$0—-$30.56M
Alkermes plcSHS(ALKS)180,5130-180,513$5.42M$0—-$5.42M
Arcturus Therapeutics Holdings Inc.(ARCT)3,4450-3,445$63.5K$0—-$63.5K
Avidity Biosciences Inc844,6330-844,633$36.80M$0—-$36.80M
Bicara Therapeutics Inc250,6060-250,606$3.96M$0—-$3.96M
Biodesix, Inc.(BDSX)49,6070-49,607$374.5K$0—-$374.5K
BridgeBio Oncology Therapeutics, Inc.(BBOT)457,4140-457,414$5.30M$0—-$5.30M
CAMP4 THERAPEUTICS CORPORATION(CAMP)653,5940-653,594$1.96M$0—-$1.96M
Cidara Therapeutics Inc220,9020-220,902$21.15M$0—-$21.15M
Crinetics Pharmaceuticals In50,0000-50,000$2.08M$0—-$2.08M
Cytokinetics, Incorporated(CYTK)211,0000-211,000$11.60M$0—-$11.60M
Delcath Systems, Inc.(DCTH)203,3860-203,386$2.19M$0—-$2.19M
Dyne Therapeutics, Inc.(DYN)100,0000-100,000$1.26M$0—-$1.26M
Enliven Therapeutics Inc10,6750-10,675$218.5K$0—-$218.5K
EyePoint, Inc.(EYPT)230,8370-230,837$3.29M$0—-$3.29M
Immunovant, Inc.(IMVT)50,0000-50,000$806.0K$0—-$806.0K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)88,9100-88,910$3.45M$0—-$3.45M
LB Pharmaceuticals Inc(LBRX)70,0000-70,000$1.11M$0—-$1.11M
MBX Biosciences, Inc.(MBX)15,0000-15,000$262.5K$0—-$262.5K
Mersana Therapeutics Inc133,6360-133,636$1.04M$0—-$1.04M
Modular Med Inc639,5310-639,531$447.5K$0—-$447.5K
MoonLake ImmunotherapeuticsCL A(MLTX)30,0000-30,000$215.1K$0—-$215.1K
Nektar Therapeutics(NKTR)3650-365$20.8K$0—-$20.8K
Pharvaris N V
COM
183,9030-183,903$4.59M$0—-$4.59M
Scholar Rock Holding Corporation(SRRK)233,9200-233,920$8.71M$0—-$8.71M
Verastem, Inc.(VSTM)1,042,7570-1,042,757$9.21M$0—-$9.21M
Zura Bio LimitedCL A(ZURA)720,4520-720,452$3.12M$0—-$3.12M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q4 2025 | TickerTrail